{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:37:54Z","timestamp":1792827474707,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82674936"],"award-info":[{"award-number":["82674936"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"DOI":"10.1007\/s11095-026-04227-9","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T18:33:13Z","timestamp":1792780393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time-Lapse Macro Imaging and LLM-Assisted Phenotypic Analysis of Release Dynamics in Nifedipine Controlled-Release Tablets"],"prefix":"10.1007","author":[{"given":"Ke","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9606-4409","authenticated-orcid":false,"given":"Li","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"issue":"2","key":"4227_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"4227_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s11095-022-03271-5","volume":"39","author":"L Deng","year":"2022","unstructured":"Deng L, Fu Y. Seeing is believing: Time-lapse macro-imaging of morphological changes of solid dosages as a teaching and research tool. Pharm Res-Dordr. 2022;39(5):1019\u201324.","journal-title":"Pharm Res-Dordr."},{"issue":"2","key":"4227_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/molecules25020338","volume":"25","author":"Y Bi","year":"2020","unstructured":"Bi Y, Lv B, Li L, Lee RJ, Xie J, Qiu Z, et al. a liposomal formulation for improving solubility and oral bioavailability of nifedipine. Molecules. 2020;25(2):338.","journal-title":"Molecules"},{"issue":"10","key":"4227_CR4","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1185\/030079906X132613","volume":"22","author":"R Conley","year":"2006","unstructured":"Conley R, Gupta SK, Sathyan G. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form. Curr Med Res Opin. 2006;22(10):1879\u201392.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"4227_CR5","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.xphs.2018.10.014","volume":"108","author":"Z Gao","year":"2019","unstructured":"Gao Z, Ngo C, Ye W, Rodriguez JD, Keire D, Sun D, et al. Effects of dissolution medium pH and simulated gastrointestinal contraction on drug release from nifedipine extended-release tablets. J Pharm Sci. 2019;108(3):1189\u201394.","journal-title":"J Pharm Sci"},{"issue":"11","key":"4227_CR6","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.3390\/pharmaceutics15112613","volume":"15","author":"M Paraschiv","year":"2023","unstructured":"Paraschiv M, Daescu M, Bartha C, Chiricuta B, Baibarac M. Complex spectroscopy studies of nifedipine photodegradation. Pharmaceutics. 2023;15(11):2613.","journal-title":"Pharmaceutics"},{"key":"4227_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jconrel.2023.08.013","volume":"361","author":"J Gengji","year":"2023","unstructured":"Gengji J, Gong T, Zhang Z, Deng L, Fu Y. Imaging techniques for studying solid dosage formulation: Principles and applications. J Control Release. 2023;361:659\u201370.","journal-title":"J Control Release."},{"issue":"7","key":"4227_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1208\/s12249-021-02080-0","volume":"22","author":"O Malallah","year":"2021","unstructured":"Malallah O, Rashid Z, Li CL, Alqurshi A, Alhanan MA, Forbes B, et al. Digital image disintegration analysis: a novel quality control method for fast disintegrating tablets. AAPS PharmSciTech. 2021;22(7):219.","journal-title":"AAPS PharmSciTech"},{"key":"4227_CR9","doi-asserted-by":"publisher","first-page":"121847","DOI":"10.1016\/j.ijpharm.2022.121847","volume":"623","author":"JX Wu","year":"2022","unstructured":"Wu JX, Balantic E, van den Berg F, Rantanen J, Nissen B, Friderichsen AV. A generalized image analytical algorithm for investigating tablet disintegration. Int J Pharmaceut. 2022;623:121847.","journal-title":"Int J Pharmaceut."},{"issue":"2","key":"4227_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11095-024-03655-9","volume":"41","author":"Y Yang","year":"2024","unstructured":"Yang Y, Gengji J, Gong T, Zhang Z, Deng L. Time-lapse macro imaging with dissolution tests for exploring the interrelationship between disintegration and dissolution behaviors of solid dosages. Pharm Res. 2024;41(2):387\u2013400.","journal-title":"Pharm Res"},{"key":"4227_CR11","doi-asserted-by":"crossref","unstructured":"Chen S, Yang Y, Mi Z, Deng L, Fu Y. Leveraging large language models to analyze solid dosage disintegration images. Acta Pharm Sin B. 2025.","DOI":"10.1016\/j.apsb.2025.11.019"},{"issue":"1","key":"4227_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11095-011-0535-1","volume":"29","author":"D Wilson","year":"2012","unstructured":"Wilson D, Wren S, Reynolds G. Linking dissolution to disintegration in immediate release tablets using image analysis and a population balance modelling approach. Pharm Res. 2012;29(1):198\u2013208.","journal-title":"Pharm Res"},{"issue":"4","key":"4227_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1109\/TIP.2003.819861","volume":"13","author":"Z Wang","year":"2004","unstructured":"Wang Z, Bovik AC, Sheikh HR, Simoncelli EP. Image quality assessment: from error visibility to structural similarity. IEEE Trans Image Process. 2004;13(4):600\u201312.","journal-title":"IEEE Trans Image Process"},{"key":"4227_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2021.08.030","volume":"338","author":"W Wang","year":"2021","unstructured":"Wang W, Ye Z, Gao H, Ouyang D. Computational pharmaceutics - a new paradigm of drug delivery. J Control Release. 2021;338:119\u201336.","journal-title":"J Control Release"},{"key":"4227_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112257","author":"J Jiang","year":"2022","unstructured":"Jiang J, Ma X, Ouyang D, Williams ROR. Emerging Artificial Intelligence (AI) technologies used in the development of solid dosage forms. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14112257.","journal-title":"Pharmaceutics"},{"key":"4227_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jconrel.2024.12.043","volume":"378","author":"N Wang","year":"2025","unstructured":"Wang N, Dong J, Ouyang D. AI-directed formulation strategy design initiates rational drug development. J Control Release. 2025;378:619\u201336.","journal-title":"J Control Release"},{"key":"4227_CR17","doi-asserted-by":"publisher","first-page":"115764","DOI":"10.1016\/j.addr.2025.115764","volume":"229","author":"N Wang","year":"2026","unstructured":"Wang N, Zhong H, Xiong P, Zhu J, Ouyang D. Quality by computational design: Harnessing AI to advance rational drug development. Adv Drug Deliver Rev. 2026;229:115764.","journal-title":"Adv Drug Deliver Rev"},{"issue":"4","key":"4227_CR18","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.apsb.2025.09.022","volume":"16","author":"Y Wu","year":"2026","unstructured":"Wu Y, Wang N, Xiong P, Wang R, Deng J, Ouyang D. Artificial intelligence for drug delivery: yesterday, today and tomorrow. Acta Pharm Sin B. 2026;16(4):2068\u201392.","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"4227_CR19","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41592-024-02334-2","volume":"21","author":"S Zhang","year":"2024","unstructured":"Zhang S, Dai G, Huang T, Chen J. Multimodal large language models for bioimage analysis. Nat Methods. 2024;21(8):1390\u20133.","journal-title":"Nat Methods"},{"issue":"8","key":"4227_CR20","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s41592-024-02310-w","volume":"21","author":"LA Royer","year":"2024","unstructured":"Royer LA. Omega\u2014harnessing the power of large language models for bioimage analysis. Nat Methods. 2024;21(8):1371\u20133. https:\/\/doi.org\/10.1038\/s41592-024-02310-w.","journal-title":"Nat Methods"},{"issue":"1","key":"4227_CR21","doi-asserted-by":"publisher","first-page":"10104","DOI":"10.1038\/s41467-024-51465-9","volume":"15","author":"D Ferber","year":"2024","unstructured":"Ferber D, W\u00f6lflein G, Wiest IC, Ligero M, Sainath S, Ghaffari Laleh N, et al. In-context learning enables multimodal large language models to classify cancer pathology images. Nat Commun. 2024;15(1):10104.","journal-title":"Nat Commun"},{"issue":"4","key":"4227_CR22","doi-asserted-by":"publisher","first-page":"e26025","DOI":"10.1016\/j.heliyon.2024.e26025","volume":"10","author":"S Waldner","year":"2024","unstructured":"Waldner S, Wendelspiess E, Detampel P, Schlep\u00fctz CM, Huwyler J, Puchkov M. Advanced analysis of disintegrating pharmaceutical compacts using deep learning-based segmentation of time-resolved micro-tomography images. Heliyon. 2024;10(4):e26025.","journal-title":"Heliyon"},{"issue":"10","key":"4227_CR23","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s11095-025-03932-1","volume":"42","author":"L Lin","year":"2025","unstructured":"Lin L, Zhou X, Yang K, Liu Y, Chen X. DeepSeek-LLM with adaptive RAG for pharmaceutical dissolution prediction. Pharm Res. 2025;42(10):1821\u201335.","journal-title":"Pharm Res"},{"issue":"1","key":"4227_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41746-024-01185-7","volume":"7","author":"Q Jin","year":"2024","unstructured":"Jin Q, Chen F, Zhou Y, Xu Z, Cheung JM, Chen R, et al. Hidden flaws behind expert-level accuracy of multimodal GPT-4 vision in medicine. NPJ Digit Med. 2024;7(1):190.","journal-title":"NPJ Digit Med"},{"issue":"2","key":"4227_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41591-024-03302-1","volume":"31","author":"R Tanno","year":"2025","unstructured":"Tanno R, Barrett DGT, Sellergren A, Ghaisas S, Dathathri S, See A, et al. Collaboration between clinicians and vision-language models in radiology report generation. Nat Med. 2025;31(2):599\u2013608.","journal-title":"Nat Med"},{"key":"4227_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3969\/j.issn.1673-5390.2023.04.008","volume":"4","author":"N Ge","year":"2023","unstructured":"Ge N, Yu QZ, Xie QY, Li TL, Luo XH. Research on the consistency evaluation of in vitro dissolution of nifedipine controlled-release tablets. China Food Drug Administration. 2023;4:80\u20135. https:\/\/doi.org\/10.3969\/j.issn.1673-5390.2023.04.008.","journal-title":"China Food Drug Administration"},{"issue":"22","key":"4227_CR27","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.13748\/j.cnki.issn1007-7693.2022.22.007","volume":"39","author":"GH Zhao","year":"2022","unstructured":"Zhao GH, Luo XJ, Peng JQ, Zhao ZM, Guo XD, Shao JH, et al. Study on correlation dissolution method of nifedipine controlled-release tablets in vitro and in vivo. Chin J Mod Appl Pharm. 2022;39(22):2945\u201351. https:\/\/doi.org\/10.13748\/j.cnki.issn1007-7693.2022.22.007.","journal-title":"Chin J Mod Appl Pharm"},{"issue":"11","key":"4227_CR28","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/cpdd.1258","volume":"12","author":"L Xin","year":"2023","unstructured":"Xin L, Chen Q, Chen D, Li Y, Li Y, Wu Q, et al. Pharmacokinetics and bioequivalence of 2 nifedipine controlled-release tablets: a randomized, single-dose, 2-period crossover study in healthy Chinese volunteers under fasting and fed conditions. Clin Pharmacol Drug Dev. 2023;12(11):1082\u20138.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"4227_CR29","unstructured":"Liu LQ, inventor; Zhejiang Weikang Pharmaceutical Co., Ltd., assignee. Nifedipine controlled-release tablet composition and preparation method thereof. China patent CN106344531A. 2017 Jan 25."},{"issue":"1","key":"4227_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0168-3659(97)01638-6","volume":"48","author":"JS Grundy","year":"1997","unstructured":"Grundy JS, Anderson KE, Rogers JA, Foster RT. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. II. Improved in vitro-in vivo correlation using a two-phase dissolution test. J Control Release. 1997;48(1):9\u201317.","journal-title":"J Control Release"},{"issue":"5","key":"4227_CR31","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s11095-011-0377-x","volume":"28","author":"JZ Duan","year":"2011","unstructured":"Duan JZ, Riviere K, Marroum P. In vivo bioequivalence and in vitro similarity factor (f2) for dissolution profile comparisons of extended release formulations: how and when do they match? Pharm Res. 2011;28(5):1144\u201356.","journal-title":"Pharm Res"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04227-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04227-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04227-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:01:49Z","timestamp":1792825309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04227-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":31,"alternative-id":["4227"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04227-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"27 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Research Involving Human Participants and\/or Animals","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, the authors used ChatGPT-5.5 (OpenAI) for English-language proofreading. The authors subsequently reviewed and edited the output and take full responsibility for the content of the manuscript.","order":3,"name":"Ethics","label":"Declaration of Generative AI and AI-Assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}